Regulators are intensifying their focus on individual accountability for compliance leadership while simultaneously finalizing new restrictions on restrictive covenants and data security protocols.
Good morning. 8 regulatory developments today — one in full below, then 7 more for subscribers.
LEAD STORY — FREE TO READ
The Federal Trade Commission (FTC) has filed a motion for civil contempt in the U.S. District Court for the District of Utah against dietary supplement provider Amare Global Holdings, its former Chief Science Officer Shawn Talbott, CEO Jared Turner, and founding partner Patrick Hintze. The filing alleges violations of a 2004 permanent injunction that prohibited Talbott and his associates from making unsubstantiated health claims regarding weight loss or disease treatment. This enforcement action follows a separate lawsuit filed earlier this month against the same parties, alleging that Amare Global operated as an illegal multi-level marketing scheme and utilized deceptive marketing to claim its products could treat mental health conditions such as depression and anxiety without competent and reliable scientific evidence.
For legal and compliance teams in the healthcare and direct selling sectors, this action underscores the enduring nature of FTC consent orders, which often carry lifetime prohibitions on specific marketing practices. Compliance officers must recognize that the FTC is increasingly targeting individual executives and high-level distributors, not just corporate entities, for "contempt of court" which bypasses the standard administrative process and can lead to immediate asset freezes or significant compensatory sanctions. Firms operating under existing orders must conduct rigorous audits of all promotional materials, including social media posts by independent contractors, as the FTC now routinely treats third-party distributor claims as direct corporate representations. Failure to maintain a robust substantiation file for health-related claims exposes firms to Section 19 redress claims and civil penalties of up to $51,744 per violation.
Market participants should monitor the court’s ruling on the FTC’s request for a preliminary injunction, as a favorable decision would likely trigger a broader industry-wide sweep of mental health-related supplement claims throughout the remainder of 2024.
Today’s briefing examines heightened enforcement activity surrounding data security protocols, emerging AI governance strategies, and the finalization of restrictive covenant prohibitions. We also analyze recent actions regarding disclosure transparency and the growing trend of individual liability for compliance leadership. Staying informed on these shifts is essential for mitigating institutional exposure and ensuring alignment with evolving oversight priorities.
Subscribe to Default to read the rest.
Become a paying subscriber of Default to get access to this post and other subscriber-only content.
Upgrade